We are monitoring the impact of COVID-19 on Latin America NGS Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 96
Share on
Share on

Latin America Next Generation Sequencing Market Research Report - By Product, By Technology, by Application, By Country (Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 96
Pages: 145

Latin America NGS Market Size (2021 to 2026)

The size of the Latin America Next Generation Sequencing Market is anticipated to grow at a CAGR of 19.06% from 2021 to 2026 and value USD 0.7 Billion by 2026.

Next-generation sequencing (NGS) is the term used to refer to several different modern sequencing techniques, often known as high-throughput sequencing. These techniques allow sequencing of DNA and RNA much faster and cheaper than commonly used Sanger sequencing, revolutionizing genomics and molecular biology research.

In healthcare markets, Latin America is a priority. This region has experienced its highest economic growth in the last four decades. Economics took nearly a quarter of the region's total population to middle-class status, with about 70% residing in Brazil, Mexico, and Argentina. Economic development has transformed into investment in the healthcare systems of this region, which in terms of expenditure on high-end biotechnology resources for clinical research and diagnostics, has increased emphasis. Genomics studies Latin America's product cycle with next-generation sequencing technology is in its exponential stage, and market growth is higher than global investment in science and technology relative to S&T spending as a relative percentage of GDP.

Factors such as Y-O-Y growth in personalized medicine, development of pre-sequencing and NGS bioinformatics solutions, cloud computing enhanced NGS application, population growth, and increased incidences of contagious diseases are majorly promoting the growth rate of the Latin American NGS market growth. However, projected declines in genome sequencing prices due to the development by key players of quick, high-capacity whole genome sequencers are expected to impact market penetration levels over the next few years positively.

One of the challenges facing Latin America's next-generation sequencing market is the processing and managing data generated by sequencing and its analysis, high quality of government grants and funding, and reduced capital expenditure from academic institutions.

This research report on the Latin American NGS Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Software
  • Services

By Technology: 

  • Targeted Re-Sequencing
  • Whole Genome Sequencing
  • De Novo Sequencing
  • Exome Sequencing
  • RNA-Seq
  • ChIP-Seq
  • Methyl-Seq

By Application: 

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture
  • Animals Research

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Regionally, the Latin American NGS market is anticipated to account for a substantial share in the global next-generation sequencing market during the forecast period. Due to the rise in investments in diagnostic research and development in Latin America, there is ample scope for the market to grow during the forecast period. In addition, the countries are focused on providing personalized treatment and therapies to the people with the use of technologies like NGS, data analytics. Moreover, the presence of advancing emerging countries such as Brazil and Mexico are expanding the market growth. In addition, economic development has resulted in increased investment in the healthcare systems of these countries, which has resulted in a greater focus on high-end biotechnology instrument spending for diagnostics and clinical research.

The Brazilian NGS market is anticipated to showcase a prominent share in the Next-generation sequencing market. Increasing preference for personalized medicine and the emergence of cloud computing as a potential data management service is projected to fuel the market growth. On the other hand, increasing incidence of cancer and declining costs of genome sequencing are further expected to upsurge the market growth.

Similarly, the Mexican NGS market is most likely to showcase a promising CAGR during the forecast period due to domestic companies' presence, increasing healthcare expenditure, a growing number of sequencing procedures, and the launch of easy-to-use consumables.

KEY MARKET PLAYERS:

Companies such as Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc, Partek Inc., Genomatix Software GmbH, Perkin Elmer Inc., GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd., DNASTAR Inc., Knome Inc., and Qiagen N.V. are a few of the promising companies operating in the Latin American NGS market.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Product  

                                5.1.1 Software

                                5.1.2 Services

                5.2 By Technology          

                                5.2.1 Whole Targeted Re-Sequencing

                                5.2.2 Genome Sequencing

                                5.2.3 De Novo Sequencing

                                5.2.4 Exome Sequencing

                                5.2.5 RNA-Seq

                                5.2.6 ChIP-Seq

                                5.2.7 Methyl-Seq

                5.3 By Application           

                                5.3.1 Diagnostics

                                5.3.2 Drug Discovery

                                5.3.3 Biomarker Discovery

                                5.3.4 Personalized Medicine

                                5.3.5 Agriculture and Animals Research

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 Brazil             

                6.3 Argentina    

                6.4 Mexico         

                6.5 Rest of Latin America             

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Macrogen Inc.           

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Thermo Fischer Scientific      

                8.3 Life Sciences (Roche)             

                8.4 Pacific Biosciences  

                8.5 Life Technologies Corp.         

                8.6 Partek Inc.  

                8.7 Genomatix Software GmbH

                8.8 Perkin Elmer inc.      

                8.9 GATC Biotech Ag      

                8.10 Agilent Technologies Inc.   

                8.11 Biomatters Ltd.      

                8.12 CLC Bio (Qiagen)    

                8.13 Pacific Biosciences

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America NGS Market, By Region, From 2021 to 2026 (USD Billion)
  2. Latin America NGS Market, By Product, From 2021 to 2026 (USD Billion)
  3. Latin America Software Market, By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Services Market, By Region, From 2021 to 2026 (USD Billion)
  5. Latin America NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  6. Latin America Whole Targeted Re-Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Genome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  8. Latin America De Novo Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Exome Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  10. Latin America RNA-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  11. Latin America ChIP-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  12. Latin America Methyl-Seq Market, By Region, From 2021 to 2026 (USD Billion)
  13. Latin America NGS Market, By Application, From 2021 to 2026 (USD Billion)
  14. Latin America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  15. Latin America Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  16. Latin America Biomarker Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  17. Latin America Personalized Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  18. Latin America Agriculture and Animals Research Market, By Region, From 2021 to 2026 (USD Billion)
  19. Brazil NGS Market, By Product, From 2021 to 2026 (USD Billion)
  20. Brazil NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  21. Brazil NGS Market, By Application, From 2021 to 2026 (USD Billion)
  22. Argentina NGS Market, By Product, From 2021 to 2026 (USD Billion)
  23. Argentina NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  24. Argentina NGS Market, By Application, From 2021 to 2026 (USD Billion)
  25. Mexico NGS Market, By Product, From 2021 to 2026 (USD Billion)
  26. Mexico NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  27. Mexico NGS Market, By Application, From 2021 to 2026 (USD Billion)
  28. Rest of Latin America NGS Market, By Product, From 2021 to 2026 (USD Billion)
  29. Rest of Latin America NGS Market, By Technology, From 2021 to 2026 (USD Billion)
  30. Rest of Latin America NGS Market, By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample